Abstract
Stiff-man syndrome is a central nervous system disorder, characterized by muscle rigidity and painful spasms, which involve mainly the muscles of the limbs, trunk, and neck. This chapter discusses the etiology, pathogenesis, clinical manifestations, diagnosis, treatment, and prognosis of this disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Moersch FP, Woltman HW. Progressive fluctuating muscular rigidity and spasm (stiff-man syndrome): report of a case and some observations in 13 other cases. Mayo Clin Proc. 1956;31:421–7.
Gordon EE, Januszko DM, Kaufman L. A critical survey of stiff-man syndrome. Am J Med. 1967;42:582–99.
Ornsteen AM. Chronic generalized fibromyositis. Ann Surg. 1935;101:237–45.
Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med. 1990;322:1555–60.
Meinck HM, Ricker K, Hulser PJ, Schmid E, Peiffer J, Solimena M. Stiff man syndrome: clinical and laboratory findings in eight patients. J Neurol. 1994;241:157–66.
Lorish TR, Thorsteinsson G, Howard FM. Stiff-man syndrome updated. Mayo Clin Proc. 1989;64:629–36.
Folli F, Solimena M, Cofiell R, Austoni M, Tallini G, Fassetta G, et al. Autoantibodies to a 128-kd protein in three women with the stiff-man syndrome and breast cancer. N Engl J Med. 1993;328:546–51.
Grimaldi LME, Martino G, Braghi S, Quattrini A, Furlan R, Bosi E, et al. Heterogeneity of autoantibodies in stiff-man syndrome. Ann Neurol. 1993;34:57–64.
Asher R. A woman with stiff-man syndrome. Br Med J. 1958;1:256–8.
O’Connor DCJ. Stiff-man syndrome. Br Med J. 1958;1:645.
Price TML, Allott EN. The stiff-man syndrome. Preliminary report of a case. Br Med J. 1958;1:682–5.
Trethowan WH, Allsop JL, Turner B. The “stiff-man” syndrome. A report of two further cases. Arch Neurol. 1960;3:448–56.
Stuart FS, Henry M, Holley HL. The stiff-man syndrome: report of a case. Arthritis Rheum. 1960;3:229–32.
Brage D. Sindrome del hombre teiso (stiff-man). Rev Clin Esp. 1959;15:30–7.
Shukla KL, Sikand P. “Stiff-man” syndrome. J Indian Med Assoc. 1961;37:610.
Werk EE, Sholiton LJ, Marnell RT. The “stiff-man” syndrome and hyperthyroidism. Am J Med. 1961;31:647–53.
Young W. The Stiff-Man syndrome. Br J Med Pract. 1966;20:507–10.
Drake Jr ME. Stiff-man syndrome and dementia. Am J Med. 1983;74:1085–7.
Ambrosetto C, Lugaresi E, Berti Ceroni G. Chronic cryptogenetic tetanus: “stiff-man” syndrome of Moersch and Woltman. G Psichiatr Neuropatol. 1966;94:511–20.
Howard Jr FM. A new and effective drug in the treatment of stiff-man syndrome: preliminary report. Mayo Clin Proc. 1963;38:203–12.
Whelam JL. Baclofen in treatment of the “stiff-man syndrome”. Arch Neurol. 1980;37:600–1.
George TM, Burke JM, Sobotka PA, Greenberg HS, Vinik AI. Resolution of stiff-man syndrome with cortisol replacement in a patient with deficiencies of ACTH, growth hormone and prolactin. N Engl J Med. 1984;47:280–7.
McQuillen MP, Tucker K, Pellegrino ED. Syndrome of acute generalized muscular stiffness and spasm. Arch Neurol. 1967;16:165–74.
Jog MS, Lambert CD, Lang AE. Stiff-person syndrome. Can J Neurol Sci. 1992;19:383–8.
Solimena M, Folli F, Denis-Donini S, Comi GC, Pozza G, De Camilli P, et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med. 1988;318:1012–20.
Martinelli P, Pazzaglia P, Montagna P, Coccagna G, Rizzuto N, Simonati S, et al. Stiff-man syndrome associated with nocturnal myoclonus and epilepsy. J Neurol Neurosurg Psychiatry. 1978;41:458–62.
Cohen L. Stiff-man syndrome: two patients treated with diazepam. JAMA. 1966;195:222–4.
Saiz A, Minguez A, Graus F, Marin C, Tolosa E, Cruz-Sanchez F. Stiff-man syndrome with vacuolar degeneration of anterior horn motor neurons. J Neurol. 1999;246:858–60.
Ishizawa K, Komori T, Okayama K, Qin X, Kaneko K, Sasaki S, et al. Large motor neuron involvement in stiff-man syndrome: a qualitative and quantitative study. Acta Neuropathol. 1999;97:63–70.
Warich-Kirches M, Von Bossanyi P, Treuheit T, Kirches E, Dietzmann K, Feistner H, et al. Stiff-man syndrome: possible autoimmune etiology targeted against GABA-ergic cells. Clin Neuropathol. 1997;16:214–9.
Westblom U. Stiff-man syndrome and clonazepam. JAMA. 1977;237:1930.
Spehlamann R, Norcross K, Rasmus SC, Schlageter NL. Improvement of stiff-man syndrome with sodium valproate. Neurology. 1981;31:162–3.
Meinck H-M, Conrad B. Neuropharmacological investigations in the stiff-man syndrome. J Neurol. 1986;233:340–7.
Boiardi A, Crenna P, Bussone G, Negri S, Merati B. Neurological and pharmacological evaluation of a case of stiff-man syndrome. J Neurol. 1980;223:127–33.
Henningsen P, Clement U, Kuchenhoff J, Simon F, Meinck HM. Psychological factors in the diagnosis and pathogenesis of stiff-man syndrome. Neurology. 1996;47:38–42.
Black JL, Barth EM, Williams DE, Tinsley JA. Stiff-man syndrome. Results of interviews and psychologic testing. Psychosomatics. 1998;39:38–44.
Tinsley JA, Barth EM, Black JL, Williams DE. Psychiatric consultations in stiff-man syndrome. J Clin Psychiatry. 1997;58:444–9.
Mitsumoto H, Schwartzman MJ, Estes ML, Chou SM, La Franchise EF, De Camilli P, et al. Sudden death and paroxysmal autonomic dysfunction in stiff-man syndrome. J Neurol. 1991;238:91–6.
Floeter MK, Valls-Solè J, Toro C, Jacobowitz D, Hallett M. Physiologic studies of spinal inhibitory circuits in patients with stiff-person syndrome. Neurology. 1998;51:85–93.
Levy LM, Dalakas MC, Floeter MK. The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid. Ann Intern Med. 1999;13:522–30.
Geis C, Weishaupt A, Grünewald B, Wultsch T, Reif A, Gerlach M, et al. Human stiff-person syndrome IgG induces anxious behavior in rats. PLoS One. 2011;6:e16775.
Bosi E, Vicari A, Comi G, Comola M, Canal N, Pozza G, et al. Association of stiff-man syndrome and type I diabetes with islet cell and other autoantibodies. Arch Neurol. 1988;45:246–7.
Oertel WH, Schmechel DE, Mugnaini E, Tappaz ML, Kopin IJ. Immunocytochemical localization of glutamate decarboxylase in rat cerebellum with a new antiserum. Neuroscience. 1981;6:2715–35.
Mugnaini E, Oertel WH. An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. In: Bjorklund A, Hokfelt T, editors. Handbook of chemical neuroanatomy, GABA and neuropeptides in the CNS, Part I, vol. 4. Amsterdam: Elsevier Science Publishers; 1985. p. 436–608.
Palay SL, Chan-Palay V. Cerebellar cortex: cytology and organization. New York: Springer; 1974.
Kaufman DL, McGinnis JF, Krieger NR, Tobin AJ. Brain glutamate decarboxilase cloned in labda γt-11: fusion protein produces gamma-aminobutyric acid. Science. 1986;232:1138–40.
Erlander MG, Tillakatne NJK, Feldblum S, Patel N, Tobin AJ. Two genes encode distinct glutamate decarboxilases. Neuron. 1991;7:91–100.
Reetz A, Solimena M, Matteoli M, Folli F, Takei K, De Camilli P. GABA and pancreatic β-cells: colocalization of glutamic acid decarboxilase (GAD) and GABA with synaptic-like microvescicles suggests their role in GABA storage and secretion. EMBO J. 1991;10:1275–84.
Vincent SR, Hokfelt T, Wu J-Y, Elde RP, Morgan LM, Kimmel JR. Immunohistochemical studies of the GABA system in the pancreas. Neuroendocrinology. 1983;36:197–204.
Persson H, Pelto-Huikko M, Metsis M, Soder O, Brene S, Skog S, et al. Expression of the neurotransmitter-synthesizing enzyme glutamic acid decarboxylase in male germ cells. Mol Cell Biol. 1990;10:4701–11.
Erdo SL, Joo F, Wolff JR. Immunohistochemical localization of glutamate decarboxylase in the rat oviduct and ovary: further evidence for non-neural GABA systems. Cell Tissue Res. 1989;255:431–4.
McEvoy KM. Stiff-man syndrome. Semin Neurol. 1991;11:197–205.
Toro C, Jacobowitz DM, Hallett M. Stiff-man syndrome. Semin Neurol. 1994;14:154–8.
Brown P, Marsden CD. The stiff man and stiff man plus syndrome. J Neurol. 1999;246:648–52.
Gorin F, Baldwin B, Tait R, Pathak R, Seyal M, Mugnaini E. Stiff-man syndrome: a GABAergic autoimmune disorder with autoantigenic heterogeneity. Ann Neurol. 1990;28:71–4.
Harding AE, Thompson PD, Kocen RS, Batchelor JR, Davey N, Marsden CD. Plasma exchange and immunosuppression in the stiff man syndrome. Lancet. 1989;2:915.
Baekkeskov S, Aanstoot H-J, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 1990;347:151–6.
Pugliese A, Gianani R, Eisenbarth GS, De Camilli P, Solimena M. Genetics of susceptibility and resistance to insulin-dependent diabetes in stiff-man syndrome. Lancet. 1994;344:1027–8.
Williams AC, Nutt JG, Hare T. Autoimmunity in stiff-man syndrome. Lancet. 1988;2:222.
Lernmark A. Glutamic acid decarboxylase – Gene to antigen to disease. J Intern Med. 1996;240:259–77.
Lohmann T, Hawa M, Leslie RDG, Lane R, Picard J, Londei M. Immune reactivity to glutamic acid decarboxylase 65 in stiff-man syndrome and type 1 diabetes mellitus. Lancet. 2000;356:31–5.
Saiz A, Arpa J, Sagasta A, Casamitjana R, Zarranz JJ, Tolosa E, et al. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology. 1997;49:1026–30.
Nemni R, Braghi S, Natali-Sora MG, Lampasona V, Bonifacio E, Comi G, et al. Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol. 1994;36:665–7.
Levy LM, Levy-Reis I, Fujii M, Dalakas MC. Brain gamma-aminobutyric acid changes in stiff-person syndrome. Arch Neurol. 2005;62:970–4.
Perani D, Garibotto V, Moresco RM, Ortelli P, Corbo M, Fazio F, et al. PET evidence of central GABAergic changes in stiff-person syndrome. Mov Disord. 2007;22:1030–3.
Galldiks N, Thiel A, Haense C, Fink GR, Hilker R. 11C-flumazenil positron emission tomography demonstrates reduction of both global and local cerebral benzodiazepine receptor binding in a patient with Stiff Person Syndrome. J Neurol. 2008;255:1361–4.
Masson C, Prier S, Benoit C, Henin D, Masson M, Cambier J. Amnesie, syndrome de l’ homme raide: Manifestations revelatrices d’une encephalomyelite paraneoplastique. Ann Med Interne. 1987;138:502–5.
Piccolo G, Cosi V, Zandrini C, Moglia A. Steroid-responsive and dependent stiff-man syndrome: a clinical and electrophysiological study of two cases. Ital J Neurol Sci. 1988;9:559–66.
Piccolo G, Cosi V. Stiff man syndrome, dysimmune disorder, and cancer. Ann Neurol. 1989;26:105.
Bateman DE, Weller RO, Kennedy P. Stiffman syndrome: a rare paraneoplastic disorder? J Neurol Neurosurg Psychiatry. 1990;53:695–6.
Silverman IE. Paraneoplastic stiff limb syndrome. J Neurol Neurosurg Psychiatry. 1999;67:126–7.
Valldeoriola F. Movement disorders of autoimmune origin. J Neurol. 1999;246:423–31.
De Camilli P, Cameron R, Greengard P. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. I. Its general distribution in synapses of the central and peripheral nervous system demonstrated by immunofluorescence in frozen and plastic sections. J Cell Biol. 1983;96:1337–54.
Navone F, Jahn R, Di Gioia G, Stukenbrok H, Greengard P, De Camilli P. Protein p38: an integral membrane protein specific for small vesicles of neurons and neuroendocrine cells. J Cell Biol. 1986;103:2511–27.
De Camilli P, Thomas A, Cofiell R, Folli F, Lichte B, Piccolo G, et al. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man Syndrome with breast cancer. J Exp Med. 1993;178:2219–23.
Dropcho EJ. Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis. Ann Neurol. 1996;43:659–67.
Perego L, Previtali SC, Nemni R, Longhi R, Carandente O, Saibene A, et al. Autoantibodies to amphiphysin II and amphiphysin II in a patient with sensory-motor neuropathy. Eur Neurol. 2002;47:196–200.
Saiz A, Dalmau J, Butler MH, Chen Q, Delattre JY, De Camilli P, et al. Anti-amphiphysin II antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma. J Neurol Neurosurg Psychiatry. 1999;66:214–7.
Antoine JC, Absi L, Honnorat J, Boulesteix JM, de Brouker T, Vial C, et al. Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors. Arch Neurol. 1999;56:172–7.
Henningsen P, Meinck HM. Specific phobia is a frequent non-motor feature in stiff man syndrome. J Neurol Neurosurg Psychiatry. 2003;74:462–5.
Nutt DJ, Malizia AL. New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry. 2001;179:390–6.
Kalueff AV, Nutt DJ. Role of GABA in anxiety and depression. Depress Anxiety. 2007;24:495–517.
Thompson PD. Stiff muscles. J Neurol Neurosurg Psychiatry. 1993;56:121–4.
Klein R, Haddow JE, DeLuca C. Familial congenital disorder resembling stiff-man syndrome. Am J Dis Child. 1972;124:730–1.
Sander JE, Layzer RB, Goldsobel AB. Congenital stiff-man syndrome. Ann Neurol. 1980;8:195–7.
Sigwald J, Guilleminault C. Syndrome de contracture permanente. Rev Neurol. 1971;124:191–212.
Rowland LP. Cramps, spasms and muscle stiffness. Rev Neurol. 1985;141:271–3.
Blum P, Jankovic J. Stiff-person syndrome: an autoimmune disease. Mov Disord. 1991;6:12–20. Review.
Fogan L. Progressive encephalomyelitis with rigidity responsive to plasmapheresis and immunosuppression. Ann Neurol. 1996;40:451–3.
Burn DJ, Ball J, Lees AJ, Behan PO, Morgan-Hughes JA. A case of progressive encephalomyelitis with rigidity and positive antiglutamic acid dehydrogenase antibodies. J Neurol Neurosurg Psychiatry. 1991;54:449–51.
Kullmann DM, Howard RS, Miller DH, Hirsch NP, Brown P, Marsden CD. Brainstem encephalopathy with stimulus-sensitive myoclonus leading to respiratory arrest, but with recovery: a description of two cases and review of the literature. Mov Disord. 1996;11:715–8.
Whiteley AM, Swash M, Urich H. Progressive encephalomyelitis with rigidity. Its relation to “subacute myoclonic spinal neuronitis” and to the “stiff-man syndrome”. Brain. 1976;99:27–42.
Campbell AG, Garland H. Subacute myoclonic spinal neuronitis. J Neurol Neurosurg Psychiatry. 1956;19:268–74.
Lhermitte F, Chain F, Escourolle R, Chedru F, Guilleminault C, Francoual M. Un nouveau cas de contracture tetaniforme distinct du “stiff man syndrome”. Etude pharmacologique et neuropathologiche d’un cas d’encephalomyelite a’ predominance medullaire. Rev Neurol. 1973;128:3–21.
Howell DA, Lees AJ, Toghill PJ. Spinal internuncial neurones in progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry. 1979;42:773–85.
Kasperek S, Zebrowski S. Stiff-man syndrome and encephalomyelitis. Arch Neurol. 1971;24:22–30.
Barker RA, Revesz T, Thom M, Marsden CD, Brown P. Review of 23 patients affected by stiff-man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff-limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry. 1998;65:633–40.
Folli F. Stiff man syndrome, 40 years later. J Neurol Neurosurg Psychiatry. 1998;65:618.
Saiz A, Graus F, Valldeoriola F, Valls-Solè J, Tolosa E. Stiff-leg syndrome: a focal form of stiff-man syndrome. Ann Neurol. 1998;43:400–1.
Shaw PJ. Stiff-man syndrome and its variants. Lancet. 1999;353:86–7.
Nguyen-Huu BK, Urban PP, Schreckenberger M, Dieterich M, Werhahn KJ. Antiamphiphysin-positive stiff-person syndrome associated with small cell lung cancer. Mov Disord. 2006;21:1285–7.
McKeon A, Pittock SJ, Lennon VA. Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease. Neurology. 2009;73:2132.
Valli G, Barbieri G, Cappa Pellegrini G, Scarlato G. Syndromes of abnormal muscular activity: overlap between continuous muscle fiber activity and the stiff-man syndrome. J Neurol Neurosurg Psychiatry. 1983;46:241–7.
Isaacs H. A syndrome of continuous muscle-fibre activity. J Neurol Neurosurg Psychiatry. 1961;24:319–25.
Leigh PN, Rothwell JC, Traub M, Marsden CD. A patient with reflex myoclonus and muscle rigidity: jerking stiff-man syndrome. J Neurol Neurosurg Psychiatry. 1980;43:1125–31.
Kimura J. Electrodiagnosis in diseases of nerve and muscle: principles and practice. Philadelphia: F.A. Davis; 1983.
Kissel JT, Elble RJ. Stiff-person syndrome. Stiff opposition to a simple explanation. Neurology. 1998;51:11–4.
Weinberg DH, Logigian EL, Kelly JJ. Cervical astrocytoma with arm rigidity: clinical and electrophysiologic features. Neurology. 1988;38:1635–7.
Sandbrink F, Syed NA, Fujii MD, Dalakas MC, Floeter MK. Motor cortex excitability in stiff-person syndrome. Brain. 2000;123:2231–9.
Walikonis JE, Lennon VA. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. Mayo Clin Proc. 1998;73:1161–6.
Rakocevic G, Raju R, Dalakas MC. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. Arch Neurol. 2004;61:902–4.
Rehman HU. Stiff-man syndrome. Postgrad Med J. 1998;74:641–2.
Link H. Characteristics of the immune response within the CNS in neurologic disorders. Acta Neurol Scand Suppl. 1978;67:177–90.
Tourtellotte WW, Walsh MJ. Cerebrospinal fluid profile in multiple sclerosis. In: Poser CM, editor. The diagnosis of multiple sclerosis. New York: Thieme Stratton; 1984. p. 165–78.
Liguori R, Medori R, Marcello L, Grimaldi L, Lugaresi E, Montagna P. Vigabatrin improves rigidity in stiff-person syndrome (SPS). Neurology. 1993;43:311.
Vermiji FH, Doorn PAV, Busch HFM. Improvement of stiff-man syndrome with vigabatrin. Lancet. 1996;346:612.
Prevett MC, Brown P, Duncan JS. Improvement of stiff-man syndrome with vigabatrin. Neurology. 1997;48:1133–4.
Stayer C, Tronnier V, Dressnandt J, Mauch E, Marquardt G, Rieke K, et al. Intrathecal baclofen therapy for stiff-man syndrome and progressive encephalomyelopathy with rigidity and myoclonus. Neurology. 1997;49:1591–7.
Maramattom BV. Intrathecal baclofen pump implantation in a case of stiff person syndrome. Neurol India. 2010;58:115–7.
Ho BL, Shih PY. Successful intrathecal baclofen therapy for seronegative stiff-person syndrome: a case report. Acta Neurol Taiwan. 2008;17:172–6.
Vicari AM, Folli F, Pozza G, Comi GC, Comola M, Canal N, et al. Plasmapheresis in the treatment of Stiff-Man Syndrome. N Engl J Med. 1989;320:1499.
Hummel M, Durinovic-Bello I, Bonifacio E, Lampasona V, Endl J, Fessele S, et al. Humoral and cellular immune parameters before and after immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus. J Neurol Neurosurgery Psychiatry. 1998;65:204–8.
Hao W, Davis C, Hirsch IB, Eng LJ, Daniels T, Walsh D, et al. Plasmapheresis and immunosuppression in stiff-man syndrome with type 1 diabetes: a 2-year study. J Neurol. 1999;246:731–5.
Brashear HR, Phillips LH. Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome. Neurology. 1991;41:1588–92.
Assessment of plasmapheresis. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1996;47:840–3.
Eiger G, Khanlou H. Long-term remission of refractory stiff-man syndrome after treatment with intravenous immunoglobulin. Mayo Clin Proc. 1999;74:1231–2.
Karlson EW, Sudarsky L, Ruderman E, Pierson S, Scott M, Helfgott SM. Treatment of stiff-man syndrome with intravenous immune globulin. Arthritis Rheum. 1994;37:915–8.
Barker RA, Marsden CD. Successful treatment of stiff-man syndrome with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry. 1997;62:426–7.
Mueller-Schoop JW, Meyer M. Total alopecia, diabetes mellitus and falls. Lancet. 1996;348:1420.
Dinkel K, Meinck H-M, Jury KM, Karges W, Richter W. Inhibition of γ-aminobutyric synthesis by glutamic decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol. 1998;44:194–201.
Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B. High-dose intravenous immune globulin for stiffperson syndrome. N Engl J Med. 2001;345:1870–6.
Gerschlager W, Brown P. Effect of treatment with intravenous immunoglobulin on quality of life in patients with stiff-person syndrome. Mov Disord. 2002;17:590–3.
Amato AA, Corman EW, Kissel JT. Treatment of stiff-man syndrome with intravenous immunoglobulin. Neurology. 1994;44:1652–4.
Gurcan HM, Ahmed AR. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders. Ann Pharmacother. 2007;41:812–23.
Elovaara I, Apostolski S, van Doorn P, Gilhus NE, Hietaharju A, Honkaniemi J, et al. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. Eur J Neurol. 2008;15:893–908.
Ishida K, Mitoma H, Song S-Y, Uchicara T, Inaba A, Eguchi S, et al. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol. 1999;46:263–7.
Butler MH, Solimena M, Dirkx R, Hayday A, De Camilli P. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in Stiff-Man Syndrome. J Exp Med. 1993;178:2097–106.
Acknowledgements
This chapter is dedicated to my beloved cousins, Maria Cristina Folli MD and Marcello Folli.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Folli, F., Prioletta, A., Quattrini, A., Galardi, G. (2014). Stiff-Man Syndrome. In: Katirji, B., Kaminski, H., Ruff, R. (eds) Neuromuscular Disorders in Clinical Practice. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6567-6_72
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6567-6_72
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6566-9
Online ISBN: 978-1-4614-6567-6
eBook Packages: MedicineMedicine (R0)